Q9Y478 (AAKB1_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 126.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: 5'-AMP-activated protein kinase subunit beta-1 Short name=AMPK subunit beta-1 Short name=AMPKb | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 270 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Non-catalytic subunit of AMP-activated protein kinase (AMPK), an energy sensor protein kinase that plays a key role in regulating cellular energy metabolism. In response to reduction of intracellular ATP levels, AMPK activates energy-producing pathways and inhibits energy-consuming processes: inhibits protein, carbohydrate and lipid biosynthesis, as well as cell growth and proliferation. AMPK acts via direct phosphorylation of metabolic enzymes, and by longer-term effects via phosphorylation of transcription regulators. Also acts as a regulator of cellular polarity by remodeling the actin cytoskeleton; probably by indirectly activating myosin. Beta non-catalytic subunit acts as a scaffold on which the AMPK complex assembles, via its C-terminus that bridges alpha (PRKAA1 or PRKAA2) and gamma subunits (PRKAG1, PRKAG2 or PRKAG3). |
| Subunit structure | AMPK is a heterotrimer of an alpha catalytic subunit (PRKAA1 or PRKAA2), a beta (PRKAB1 or PRKAB2) and a gamma non-catalytic subunits (PRKAG1, PRKAG2 or PRKAG3). Interacts with FNIP1 and FNIP2. Ref.7 Ref.8 Ref.18 |
| Domain | The glycogen-binding domain may target AMPK to glycogen so that other factors like glycogen-bound debranching enzyme or protein phosphatases can directly affect AMPK activity By similarity. |
| Post-translational modification | Phosphorylated when associated with the catalytic subunit (PRKAA1 or PRKAA2). Phosphorylated by ULK1; leading to negatively regulate AMPK activity and suggesting the existence of a regulatory feedback loop between ULK1 and AMPK. Ref.15 |
| Sequence similarities | Belongs to the 5'-AMP-activated protein kinase beta subunit family. |
| Sequence caution | The sequence AAB71326.1 differs from that shown. Reason: Erroneous gene model prediction. The sequence AAC98897.1 differs from that shown. Reason: Frameshift at position 245. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| GRB2 | P62993 | 2 | EBI-719769,EBI-401755 | |
| PRKAG1 | P54619 | 3 | EBI-719769,EBI-1181439 |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 270 | 270 | 5'-AMP-activated protein kinase subunit beta-1 | PRO_0000204363 | |||||
Regions | |||||||||
| Region | 68 – 163 | 96 | Glycogen-binding domain By similarity | ||||||
Amino acid modifications | |||||||||
| Modified residue | 4 | 1 | Phosphothreonine Ref.9 | ||||||
| Modified residue | 5 | 1 | Phosphoserine Ref.9 | ||||||
| Modified residue | 6 | 1 | Phosphoserine Ref.9 | ||||||
| Modified residue | 19 | 1 | Phosphothreonine Ref.10 Ref.12 | ||||||
| Modified residue | 24 | 1 | Phosphoserine; by autocatalysis By similarity | ||||||
| Modified residue | 25 | 1 | Phosphoserine; by autocatalysis By similarity | ||||||
| Modified residue | 40 | 1 | Phosphoserine Ref.10 Ref.12 Ref.14 | ||||||
| Modified residue | 96 | 1 | Phosphoserine Ref.13 | ||||||
| Modified residue | 101 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 108 | 1 | Phosphoserine Ref.9 Ref.10 Ref.11 Ref.12 Ref.13 Ref.14 Ref.17 | ||||||
| Modified residue | 148 | 1 | Phosphothreonine Ref.12 | ||||||
| Modified residue | 182 | 1 | Phosphoserine By similarity | ||||||
| Lipidation | 2 | 1 | N-myristoyl glycine | ||||||
Experimental info | |||||||||
| Mutagenesis | 2 | 1 | G → A: Abolishes myristoylation and AMP-enhanced phosphorylation of PRKAA1 or PRKAA2. Ref.18 | ||||||
| Sequence conflict | 10 | 1 | A → G in CAA73146. Ref.2 | ||||||
| Sequence conflict | 10 | 1 | A → G in AAC98897. Ref.4 | ||||||
| Sequence conflict | 15 | 1 | G → A in CAA12024. Ref.1 | ||||||
| Sequence conflict | 20 | 1 | P → A in CAA73146. Ref.2 | ||||||
| Sequence conflict | 20 | 1 | P → A in AAC98897. Ref.4 | ||||||
| Sequence conflict | 22 | 1 | R → K in AAD09237. Ref.3 | ||||||
| Sequence conflict | 22 | 1 | R → K in AAD00625. Ref.3 | ||||||
| Sequence conflict | 56 | 1 | E → Y in AAD09237. Ref.3 | ||||||
| Sequence conflict | 56 | 1 | E → Y in AAD00625. Ref.3 | ||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Non-catalytic beta and gamma subunits isoforms of the AMP-activated protein kinase." Carling D. Submitted (FEB-1998) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
| [2] | "AMP-activated protein kinase isoenzyme family: subunit structure and chromosomal location." Stapleton D., Woollatt E., Mitchelhill K., Nicholl J.K., Fernandez C.S., Michell B.J., Witters L.A., Power D.A., Sutherland G.R., Kemp B.E. FEBS Lett. 409:452-456(1997) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Tissue: Brain. |
| [3] | "Transcription map of the 5cM region surrounding the hepatocyte nuclear factor-1a/MODY3 gene on chromosome 12." Yamagata K., Oda N., Furuta H., Vaxillaire M., Southam L., Boriraj V., Chen X., Oda Y., Takeda J., Yamada S., Nishigori H., Lebeau M.M., Lathrop M., Cox R.D., Bell G.I. Submitted (JAN-1997) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA]. |
| [4] | "Cloning and expression of the complete mRNA coding human AMP-activated protein kinase." Wang X., Yu L., Tu Q. Submitted (JAN-1999) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
| [5] | "The finished DNA sequence of human chromosome 12." Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R. Gibbs R.A.Nature 440:346-351(2006) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [6] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Lung and Muscle. |
| [7] | "Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling." Baba M., Hong S.-B., Sharma N., Warren M.B., Nickerson M.L., Iwamatsu A., Esposito D., Gillette W.K., Hopkins R.F. III, Hartley J.L., Furihata M., Oishi S., Zhen W., Burke T.R. Jr., Linehan W.M., Schmidt L.S., Zbar B. Proc. Natl. Acad. Sci. U.S.A. 103:15552-15557(2006) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH FNIP1. |
| [8] | "Identification and characterization of a novel folliculin-interacting protein FNIP2." Hasumi H., Baba M., Hong S.-B., Hasumi Y., Huang Y., Yao M., Valera V.A., Linehan W.M., Schmidt L.S. Gene 415:60-67(2008) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH FNIP2. |
| [9] | "Phosphoproteome of resting human platelets." Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J., Schuetz C., Walter U., Gambaryan S., Sickmann A. J. Proteome Res. 7:526-534(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-4; SER-5; SER-6 AND SER-108, MASS SPECTROMETRY. Tissue: Platelet. |
| [10] | "Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle." Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R., Greff Z., Keri G., Stemmann O., Mann M. Mol. Cell 31:438-448(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-19; SER-40 AND SER-108, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [11] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-108, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [12] | "Large-scale proteomics analysis of the human kinome." Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G., Mann M., Daub H. Mol. Cell. Proteomics 8:1751-1764(2009) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-19; SER-40; SER-108 AND THR-148, MASS SPECTROMETRY. |
| [13] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-96 AND SER-108, MASS SPECTROMETRY. Tissue: Leukemic T-cell. |
| [14] | "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis." Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M. Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-40 AND SER-108, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [15] | "Ulk1-mediated phosphorylation of AMPK constitutes a negative regulatory feedback loop." Loffler A.S., Alers S., Dieterle A.M., Keppeler H., Franz-Wachtel M., Kundu M., Campbell D.G., Wesselborg S., Alessi D.R., Stork B. Autophagy 7:696-706(2011) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION BY ULK1. |
| [16] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [17] | "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation." Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B. Sci. Signal. 4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-108, MASS SPECTROMETRY. |
| [18] | "AMPK is a direct adenylate charge-regulated protein kinase." Oakhill J.S., Steel R., Chen Z.P., Scott J.W., Ling N., Tam S., Kemp B.E. Science 332:1433-1435(2011) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH PRKAA1 AND PRKAG1, MUTAGENESIS OF GLY-2. |
| [19] | "AMP-activated protein kinase in metabolic control and insulin signaling." Towler M.C., Hardie D.G. Circ. Res. 100:328-341(2007) [PubMed] [Europe PMC] [Abstract] Cited for: REVIEW ON FUNCTION. |
| [20] | "AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy." Hardie D.G. Nat. Rev. Mol. Cell Biol. 8:774-785(2007) [PubMed] [Europe PMC] [Abstract] Cited for: REVIEW ON FUNCTION. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AJ224515 mRNA. Translation: CAA12024.1. Y12556 mRNA. Translation: CAA73146.1. U83994 mRNA. Translation: AAD09237.1. U87276 U87275 Genomic DNA. Translation: AAD00625.1.AF022116 mRNA. Translation: AAC98897.1. Frameshift. AC002563 Genomic DNA. Translation: AAB71326.1. Sequence problems. BC001007 mRNA. Translation: AAH01007.1. BC001056 mRNA. Translation: AAH01056.1. BC001823 mRNA. Translation: AAH01823.1. BC017671 mRNA. Translation: AAH17671.1. |
| IPI | IPI00220409. |
| PIR | T09514. |
| RefSeq | NP_006244.2. NM_006253.4. |
| UniGene | Hs.741184. |
3D structure databases | |
| ProteinModelPortal | Q9Y478. |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | Q9Y478. 13 interactions. |
| MINT | MINT-1400840. |
| STRING | 9606.ENSP00000229328. |
Protein family/group databases | |
| CAZy | CBM48. Carbohydrate-Binding Module Family 48. |
PTM databases | |
| PhosphoSite | Q9Y478. |
Polymorphism databases | |
| DMDM | 14194425. |
Proteomic databases | |
| PaxDb | Q9Y478. |
| PRIDE | Q9Y478. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000229328; ENSP00000229328; ENSG00000111725. ENST00000541640; ENSP00000441369; ENSG00000111725. |
| GeneID | 5564. |
| KEGG | hsa:5564. |
| UCSC | uc001txg.3. human. |
Organism-specific databases | |
| CTD | 5564. |
| GeneCards | GC12P120105. |
| HGNC | HGNC:9378. PRKAB1. |
| HPA | CAB005058. HPA004247. |
| MIM | 602740. gene. |
| neXtProt | NX_Q9Y478. |
| PharmGKB | PA33746. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | NOG238368. |
| HOGENOM | HOG000230597. |
| HOVERGEN | HBG050430. |
| InParanoid | Q9Y478. |
| KO | K07199. |
| OMA | PYICKPE. |
| OrthoDB | EOG4G1MH4. |
| PhylomeDB | Q9Y478. |
Enzyme and pathway databases | |
| Pathway_Interaction_DB | mtor_4pathway. mTOR signaling pathway. |
| Reactome | REACT_111102. Signal Transduction. REACT_11123. Membrane Trafficking. REACT_11163. Activated AMPK stimulates fatty-acid oxidation in muscle. |
Gene expression databases | |
| ArrayExpress | Q9Y478. |
| Bgee | Q9Y478. |
| CleanEx | HS_PRKAB1. |
| Genevestigator | Q9Y478. |
| GermOnline | ENSG00000111725. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR006828. AMP_prot_kin_bsu_interact-dom. [Graphical view] |
| Pfam | PF04739. AMPKBI. 1 hit. [Graphical view] |
| SMART | SM01010. AMPKBI. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| BindingDB | Q9Y478. |
| ChEMBL | CHEMBL3847. |
| DrugBank | DB00131. Adenosine monophosphate. DB00331. Metformin. |
| GenomeRNAi | 5564. |
| NextBio | 21556. |
| SOURCE | Search... |
Entry information
| Entry name | AAKB1_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q9Y478 Secondary accession number(s): Q9UBV0 Q9Y6V8 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 12 Human chromosome 12: entries, gene names and cross-references to MIM |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
